Immunohistochemistry in hollow urinary tract
Ceskoslovenska patologie.
2020 Summer ;
56 (3) :
140-152.
Language English Country Czech Republic Media print
Document type Journal Article, Review
Persistent link
https://www.medvik.cz/link/pmid33076666
PubMed
33076666
PII: 123962
Knihovny.cz E-resources
- Keywords
- immunohistochemistry, nested-variant of urothelial carcinoma, prostatic adenocarcinoma, urothelial carcinoma, urothelial carcinoma in situ,
- MeSH
- Diagnosis, Differential MeSH
- Immunohistochemistry MeSH
- Humans MeSH
- Biomarkers, Tumor MeSH
- Urinary Bladder Neoplasms * diagnosis MeSH
- Urothelium MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Review MeSH
- Names of Substances
- Biomarkers, Tumor MeSH
There is no ideal marker or established immunohistochemistry panel to confirm urothelial differentiation. Immunohistochemistry must be always indicated in concrete differential diagnostic consideration. In this review article, immunohistochemistry will be discussed in the three different settings - distinction of benign and malignant changes of urothelium, the most frequent pitfalls and non-urothelial neoplasms of urinary tract.
